Michael Barrett Email Address
@intarcia.com
Data Officer
Intarcia Therapeutics, Inc., incorporated in June 1995, is a biopharmaceutical company with an approach to acquire, develop and commercialize therapeutic products for the treatment of cancer and infectious diseases. The Company is developing atamestane, its aromatase inhibitor, in combination with toremifene, an approved estrogen receptor blocker, for the treatment of hormone-dependent breast cancer in postmenopausal women. During the year ended December 31, 2004, Intarcia Therapeutics, Inc. was in Phase III clinical development with this combination for the initial or first line treatment of hormone-dependent advanced (metastatic or locally advanced) breast cancer in postmenopausal women. It is developing omega DUROS, a subcutaneous implant designed to deliver its omega interferon, for the treatment of hepatitis C. The Company has completed a Phase II clinical trial of omega interferon.
Health and Life Sciences Business Technology executive with extensive experience in Management Consulting. Expertise in the areas of Information Management & Strategy, Business Analytics, Enterprise Data Integration Architectures and Master Data Organization Design. Background includes the design and delivery of business driven technology solutions for Fortune 500 Health Care companies across pharmaceutical, bio-technology and medical device companies.
Other people working at Intarcia Therapeutics:
How does this work?
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you're looking to find the email of Michael Barrett at Intarcia Therapeutics then you've come to the right place.
Wondering if it's michael@intarcia.com, michael.barrett@intarcia.com, barrett@intarcia.com, or mbarrett@intarcia.com? We have the answers for you.